Transgenic mouse models of human CYP3A4 gene regulation

Molecular Pharmacology

Volumn 64, Issue 1, 2003, Pages 42-50

  Robertson, Graham R ^a   Field, Jacqueline ^a   Goodwin, Bryan ^a,b   Bierach, Sandra ^a   Tran, Minh ^a   Lehnert, Anne ^a   Liddle, Christopher ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b GLAXOSMITHKLINE   (United States)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA CARBONITRILE; BETA GALACTOSIDASE; CONSTITUTIVE ANDROSTANE RECEPTOR; CYANIDE; CYTOCHROME P450 3A4; DEXAMETHASONE; DRUG METABOLIZING ENZYME; PHENOBARBITAL; PREGNANE X RECEPTOR; PREGNENOLONE; STEROID RECEPTOR; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOSE RESPONSE; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE SEQUENCE; HISTOCHEMISTRY; LACTOSE OPERON; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SEQUENCE ANALYSIS; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE TRANSFER TECHNIQUES; HUMANS; MALE; MICE; MICE, TRANSGENIC;

EID: 0038575830     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.1.42     Document Type: Article

References (40)

1. Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, and Gelboin HV (1989) Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver, cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem 264:10388-10395.
2. Araya Z and Wikvall K (1999) 6α-Hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes. Biochim Biophys Acta 1438:47-54.
3. Barwick JL, Quattrochi LC, Mills AS, Potenza C, Tukey RH, and Guzelian PS (1996) Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Mol Pharmacol 50:10-16.
4. Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Backman M, Ohlsson R, Postlind H, Blomquist P, and Berkenstam A (1998) Identification of a human nuclear receptor defines a new signalling pathway for CYP3A induction. Proc Natl Acad Sci USA 95:12208-12213.
5. Blumberg B, Sabbagh W Jr, Juguilon H, Bolado J Jr, van Meter CM, Ong ES, and Evans RM (1998) SXR, a novel steroid and xenobiotic sensing nuclear receptor. Genes Dev 12:3195-3205.
6. Brian WR, Sari MA, Iwasaki M, Shimada T, Kaminsky LS, and Guengerich FP (1990) Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae. Biochemistry 29:11280-11292.
7. Burk O, Tegude H, Koch I, Hustert E, Wolbold R, Glaeser H, Klein K, Fromm MF, Nuessler AK, Neuhaus P, et al. (2002) Molecular mechanism of polymorphic CYP3A7 expression in adult human liver and intestine. J Biol Chem 277:24280-24288.
8. Foster R, Jahroudi N, Varshney U, and Gedamu L (1988) Structure and expression of the human metallothionein-IG gene. Differential promoter activity of two linked metanothionein-I genes in response to heavy metals. J Biol Chem 263:11528-11535.
9. Genner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, et al. (2001) Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics 11:111-121.
10. Goodwin B, Hodgson E, D'Costa DJ, Robertson GR, and Liddle C (2002) Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol Pharmacol 62:359-365.
11. Goodwin BJ, Hodgson E, and Liddle C (1999) The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 56:1329-1339.
12. Goring DR, Rossant J, Clapoff S, Breitman ML, and Tsui LC (1987) In situ detection of β-galactosidase in lenses of transgenic mice with a γ-crystallin/lacZ gene. Science (Wash DC) 235:456-458.
13. Itoh S, Satoh M, Abe Y, Hashimoto H, Yanagimoto T, and Kamataki T (1994) A novel form of mouse cytochrome P450 3A (Cyp3A-16). Its cDNA cloning and expression in fetal liver. Eur J Biochem 226:877-882.
14. Koch I, Weil R, Wolbold R, Brockmoller J, Hustert E, Burk O, Nuessler A, Neuhaus P, Eichelbaum M, Zanger U, et al. (2002) Interindividual variability and tissue-specificity in the expression of cytochrome p450 3A mRNA. Drug Metab Dispos 30:1108-1114.
15. Kolars JC, Lown KS, Schmiedlin-Ren P, Ghosh M, Fang C, Wrighton SA, Merion RM, and Watkins PB (1994) CYP3A expression in human gut epithelium. Pharmacogenetics 4:247-259.
16. Komori M, Nishio K, Fujitani T, Ohi H, Kitada M, Mima S, Itahashi K, and Kamataki T (1989) Isolation of a new human fetal liver cytochrome P450 cDNA clone: evidence for expression of a limited number of forms of cytochrome P450 in human fetal livers. Arch Biochem Biophys 272:219-225.
17. Lacroix D, Sonnier M, Moncion A, Cheron G, and Cresteil T (1997) Expression of CYP3A in the human liver - evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247:625-634.
18. Lamba JK, Lin YS, Thummel K, Daly A, Watkins PB, Strom S, Zhang J, and Schuetz EG (2002) Common allelic variants of cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics 12:121-132.
19. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, and Kliewer SA (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Investig 102:1016-1023.
20. Liddle C, Goodwin BJ, George J, Tapner M, and Farrell GC (1998) Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab 83:2411-2416.
21. Lin YS, Dowling AL, Quigley SD, Farin FM, Zhang J, Lamba J, Schuetz EG, and Thummel KE (2002) Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. Mol Pharmacol 62:162-172.
22. Maurel P (1996). The CYP3 family, in Cytochromes P450: Metabolic and Toxicological Aspects (Ioannides C ed) pp. 241-270, CRC Press, Inc., Boca Raton, FL.
23. Mode A, Tollet P, Strom A, Legraverend C, Liddle C, and Gustafsson JA (1992) Growth hormone regulation of hepatic cytochrome P450 expression in the rat. Adv Enzyme Regul 32:255-263.
24. Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, and Kliewer SA (2000a) St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97:7500-7502.
25. Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM (2000b) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275:15122-15127.
26. Nebert DW and Gonzalez FJ (1987) P450 genes: structure, evolution and regulation. Annu Rev Biochem 56:945-993.
27. Pai HV, Upadhya SC, Chinta SJ, Hegde SN, and Ravindranath V (2002) Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite. Pharmacogenomics J 2:243-258.
28. Park S-H, Liu X, Hennighausen L, Davey HW, and Waxman DJ (1999) Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression. J Biol Chem 274:7421-7430.
29. Sakuma T, Takai M, Endo Y, Kuroiwa M, Ohara A, Jarukamjorn K, Honma R, and Nemoto N (2000) A novel female-specific member of the CYP3A gene subfamily in the mouse liver. Arch Biochem Biophys 377:153-162.
30. Schuetz JD, Kauma S, and Guzelian PS (1993) Identification of the fetal liver cytochrome 3A7 in human endometrium and placenta. J Clin Investig 92:1018-1024.
31. Schuetz JD, Beach DL, and Guzelian PS (1994) Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4:11-20.
32. Shimada T, Yamazaki H, Mimura M, Inui Y, and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
33. Spurdle AB, Goodwin B, Hodgson E, Hopper JL, Chen X, Purdie DM, McCredie MRE, Giles GG, Chenevix-Trench G, and Liddle C (2002) The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. Pharmacogenetics 12:355-366.
34. Upadhya SC, Chinta SJ, Pai HV, Boyd MR, and Ravindranath V (2002) Toxicological consequences of differential regulation of cytochrome P450 isoforms in rat brain regions by phenobarbital. Arch Biochem Biophys 399:56-65.
35. Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, and Guzelian PS (1989) Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. J Clin Investig 83:688-697.
36. Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, Molowa DT, and Vandenbranden M (1990) Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 38:207-213.
37. Xie W, Barwick JL, Downes M, Blumberg B, Simon CM, Nelson MC, Neuschwander-Tetri BA, Brunt E, Guzelian PS, and Evans RM (2000a) Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature (Lond) 406:435-439.
38. Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, and Evans RM (2000b) Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev 14:3014-3023.
39. Yamada H, Gohyama N, Honda S, Hara T, Harada N, and Oguri K (2002) Estrogen-dependent regulation of the expression of hepatic Cyp2b and 3a isoforms: assessment using aromatase-deficient mice. Toxicol Appl Pharmacol 180:1-10.
40. Yokose T, Doy M, Taniguchi T, Shimada T, Kakiki M, Horie T, Matsuzaki Y, and Mukai K (1999) Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues. Virchows Arch 434:401-411.